My focus at Reveal is shared between business strategy and leading detection/quantification product development efforts. Our key technologies use next generation pathology tools that combine novel nanotechnology detection, hyperspectral whole slide microscope tissue imaging and quantification. We're integrating traditional histopathology techniques with novel chemistry, automation and distributed big data tools as a service for our biotech and pharma clients.
My background is generally involved in making new products or businesses. I've been fortunate to work on some great projects with real potential for significant societal impact that include a mixture of full stack hardware/software...